MedBright AI Investments Inc. (Ticker: MBAI.c or MBAIF for US investors) has introduced its AI-Powered Limmi Disease Insights Platform at UC San Diego University Hospital, marking a potential advancement in the detection of kidney stone recurrence through AI technology.
The Limmi Disease Insights Platform, unveiled in partnership with UC San Diego Health, represents a pioneering effort to leverage artificial intelligence in healthcare. By integrating sophisticated AI modeling and extensive data analysis, the platform aims to provide personalized risk assessments for kidney stone recurrence, a critical aspect of patient care.
Dr. Roger Sur, from UC San Diego School of Medicine, emphasizes the importance of personalized risk prediction in managing diseases like kidney stones and recognizes the transformative potential of AI in healthcare.
"We know that recurring kidney stones affect approximately 50% of patients—but we don't have a personalized risk predictor for individual patients. We have fortunately collected years of high quality kidney stone patient data to apply to Artificial Intelligence (AI). The goal is to create a high fidelity AI model that will predict an individual's risk of kidney stone recurrence."
Looking ahead, MedBright AI Investments Inc. plans to expand the application of the Limmi AI technology to predict and manage other diseases, demonstrating its commitment to revolutionizing healthcare with AI.
Despite its current market capitalization below $20M, MedBright AI Investments Inc. has made significant strides in the healthcare sector. In just two months, the company secured agreements with 14 clinics across North America to use its AI Health-Tech Offerings.
These achievements along with the most recent deal with UC San Diego underscore MedBright AI's potential for growth within the healthcare industry, demonstrating its ability to deliver innovative solutions that address critical healthcare challenges.
Full press release: https://www.globenewswire.com/news-release/2024/02/22/2833631/0/en/MedBright-AI-Announces-Limmi-Disease-Insights-Platform-Being-Used-in-University-Hospital-Setting-to-Improve-Detection-of-Kidney-Stone-Disease-Recurrence.html
Posted on behalf of Medbright AI Investments Inc.